期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

绝经后受体阳性晚期乳腺癌内分泌治疗回顾与展望 被引量：4

原文传递
导出
摘要 乳腺癌是全球范围内女性最常见的恶性肿瘤。在我国上海、北京等大城市以及部分沿海城市，乳腺癌发病率已占女性恶性肿瘤的第一位。我国乳腺癌患者中40％为绝经后妇女，70％激素受体阳性。这些乳腺癌患者30％最终会出现复发转移。理论上讲，转移性乳腺癌（MBC）是不可治愈性疾病，治疗的目的是尽可能地延长患者高质量的生存期。
作者 王佳玉 徐兵河
机构地区 中国医学科学院北京协和医学院肿瘤研究所肿瘤医院内科
出处 《中华医学杂志》 CAS CSCD 北大核心 2012年第19期1297-1299,共3页 National Medical Journal of China
关键词 晚期乳腺癌 内分泌治疗 绝经后妇女 激素受体 阳性 女性恶性肿瘤 乳腺癌患者 转移性乳腺癌
分类号 R737.9 [医药卫生—肿瘤]
  • 相关文献

参考文献19

  • 1姚舒洋,徐兵河,李青,张频,王佳玉,袁芃,马飞,蔡瑞刚.戈舍瑞林联合阿那曲唑治疗晚期绝经前乳腺癌的临床观察[J].中华医学杂志,2010,90(8):526-528. 被引量：16
  • 2Er O, Frye DK, Kau SW, et al. Clinical course of breast cancer patients with metastases limited to the liver treated with chemotherapy. Cancer J, 2008,141:62-68.
  • 3Petru E, Schmahl D. On the role of additive hormone monotherapy with tamoxifen, medroxyprogesterone acetate and aminoglutethimide, in advanced breast cancer. Klin Wochenschr, 1987, 65:959-966.
  • 4Milla-Santos A, Milla L, Rallo L, et al. Phase Ⅲ randomized trial of toremifene vs tamoxifen in hormono-dependant advanced breast cancer. Breast Cancer Res Treat ,2001,65 : 119-124.
  • 5Mouridsen H, Gershanovich M, Sun Y, et al. Superior efficacy of letrozole versus tamoxifen as first-line therapy for postmenopausal women with advanced breast cancer:results of a phase Ⅲ study of the international Letrozole Breast Cancer Group. J Clin Oncol, 2003, 21:2101-2109.
  • 6Nabholtz JM, Buzdar A, PollakM, et al. Anastrozole is superior to tamoxifen as first-line therapy for advanced breast carcinoma in postmenopausal women: results of a North American multicenter randomized trial. J Clin Oncol, 2000,18:3758-3767.
  • 7Bonneterre J, Thurlimann B, Robertson JFR, et al. Anastrozole versus tamoxifen as first-line therpy for advanced Breast cancer in 668 Postmenopausal women : results of the Tamoxifen or Afimidex Randomized Group Efficacy And Tolerability stuydy. J Clin Oncol, 2000,18:3748-3757.
  • 8Robertson J, Osborne CK, Howell A et al. Fulvestrant versus anastrozole for the treatment of advanced breast carcinoma in postmenopausal women: a prospective combined analysis of two multicenter trial. Cancer, 2003, 98:229-238.
  • 9Howell A, Robertson JF, Abram P, et al. Comparison of Fulvestrant versus tamoxifen for the treatment of advanced breast cancer in postmenopausal women previously untreated with endocrine therapy: a multinational, double-blind, randomized trial. J Clin Oncol, 2004,22:1605-1613.
  • 10Xu BH, Jiang Z, Shao Z, et al. Fulvestrant 250 mg versus anastrozole for Chinese patients with advanced breast cancer: results of a muhicentre, double-blind, randomised phase Ⅲ trial Cancer Chemother Pharmacol, 2011,67:223-230.

二级参考文献27

  • 1Parkin DM,Bray F,Ferlay J,et al.Global cancer statistics,2002.CA Cancer J Clin,2005,55:74-108.
  • 2Landis SH,Murray T,Bolden S,et al.Cancer statistics,1999.CA Cancer J Clin,1999,49:8-31.
  • 3Greeaberg PA,Hortobagyi GN,Smith TL,et al.Long-term follow-up of patients with complete remission following combination chemotherapy for metastatic breast cancer.J Clin Oncol,1996,14:2197-2205.
  • 4Forward DP,Cheung KL,Jackson L,et al.Clinical and endocrine data for goserelin plus anastrozole as second-line endocrine therapy for premenopausal advanced breast cancer.Br J Cancer,2004,90:590-594.
  • 5Carlson RW,Schurman CM,Rivera E,et al.Goserelin plus anastrozole for the treatment of premenopausal women with hormone receptor positive,recurrent/metastatic breast cancer.Breast Cancer Res Treat,2004,88:S237.
  • 6Therasse P,Arbuck SG,Eisenhauer EA,et al.New guidelines to evaluate the response to treatment in solid tumors.European Organization for Research and Treatment of Cancer,National Cancer Institute of the United States,National Cancer Institute of Canada.J Nail Cancer Inst,2000,92:205-216.
  • 7De Maio E,Gravina A,Pacilio C,et al.Compliance and toxicity of adjuvant CMF in elderly breast cancer patients:a single-center experience.BMC Cancer,2005,5:30.
  • 8Klijn JG,Beet LV,Mauriac L,et al.Combined treatment with buserelin and tamoxifen in premenopausal metastatic breast cancer:a randomized study.J Natl Cancer Inst,2000,92:903-911.
  • 9Boccardo F,Rubagotti A,Perrotta A,et al.Ovarian ablation versus goserelin with or without tamoxifen in pre-perimenopausal patients with advanced breast cancer:results of a multicentric italian study.Ann Oncol,1994,5:337-342.
  • 10Jonst W,Kaufmann M,Blarney RW,et al.A randomised study to compare the effect of the luteinising hormone releasing hormone (LHRH) analogue gosereliu with or without tamoxifen in pre-and perimenopausal patients with advanced breast cancer.Eur J Cancer,1995,31A:137-142.

共引文献28

同被引文献33

  • 1山东中医学院,河北医学院校释.黄帝内经素问校释[M].北京:人民卫生出版社,1982.2.27.420.
  • 2明·薛己.薛氏医案选[M].北京:人民卫生出版社,1983.
  • 3金·李东垣.脾胃论[M].北京:人民卫生出版社,2005
  • 4汤钊猷.现代肿瘤学[M].3版.上海:复旦大学出版社,2011:890-931.
  • 5明·张介宾.景岳全书[M].影印本.上海:上海科技出版社,1991:34,915.
  • 6明·李中梓.医宗必读[M].北京:中国医药科技出版社,2011:321.
  • 7Li J,Zhang BN,Fan JH,et al.A nation-wide multicenter 10-year(1999-2008)retrospective clinical epidemiological study of femal breast cancer in China[J].BMC Cancer,2011,11:364-375.
  • 8陆徳铭工作室,编著.陆徳铭学术经验撷英[M].上海:上海中医药大学出版社,2010:46-50.
  • 9Er O,Frye DK,Kau SW,et al.Clinical course of breast cancer patients with metastases limited to the liver treated with chemotherapyl[J].Cancer J,2008,141:62-68.
  • 10Buzdar Au,Jonat W,Howell A,et al.Anastrozole versus megstrol acetate in the treatment of postmenopausal women on a combined analysis of data from two mature phase Ⅲ trials.Arimidex study Group[J].Cancer,1998,83 (6):1142-1152.

引证文献4

二级引证文献26

中华医学杂志
2012年 第19期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部